Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268606
Status:
COMPLETED
Last Update Posted:
2008-05-21
First Post:
2005-12-21
Brief Title:
Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk
Sponsor:
ZonMw The Netherlands Organisation for Health Research and Development
Organization:
Radboud University Medical Center
Study Overview
Official Title:
Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2008-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The present study is a new approach of examining tailored cognitive-behavioral interventions for fibromyalgia patients at risk For this purpose fibromyalgia patients are screened with respect to cognitive-behavioral risk factors and these patients are offered tailored cognitive-behavioral treatment options It is expected that this approach will result in increased magnitude and maintenance of effects
Detailed Description:
The fibromyalgia syndrome is a chronic condition with widespread pain that poses a great challenge for patients rheumatologists and society because of the lack of optimal treatment options There is extensive evidence that in comparison with patients with rheumatoid arthritis fibromyalgia patients report higher levels of functional disability pain fatigue and lower levels of quality of life Although effectiveness of pharmacological agents and other interventions is generally limited most promising effects have been found for non-pharmacological treatments particularly those with a primary focus on cognitive-behavioral treatment components However also these treatment outcomes are characterized by large individual variation Particularly patients with less impairments in daily life seem to benefit less from these treatments In line with the international literature previous findings of the research group suggest that effectiveness might be increased when tailored cognitive-behavioural treatments are solely offered to patients at risk
In the present project the effects of tailored interventions based on cognitive-behavioral factors for patients at risk are studied In a randomized controlled trial fibromyalgia patients are screened for risk profiles Patients at risk will be assigned to tailored cognitive or behavioral treatment conditions depending on their risk profile with respect to cognitive-behavioral factors Half of the patients are subsequently randomly assigned to a waiting list control condition It is expected that this tailored treatment approach will increase magnitude and maintenance of treatment effects for pain disability fatigue and increased quality of life which means an important step forward for patients involved professionals and society
In the present project the effects of tailored interventions based on cognitive-behavioral factors for patients at risk are studied In a randomized controlled trial fibromyalgia patients are screened for risk profiles Patients at risk will be assigned to tailored cognitive or behavioral treatment conditions depending on their risk profile with respect to cognitive-behavioral factors Half of the patients are subsequently randomly assigned to a waiting list control condition It is expected that this tailored treatment approach will increase magnitude and maintenance of treatment effects for pain disability fatigue and increased quality of life which means an important step forward for patients involved professionals and society
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NR 05-1-1101 | None | None | None |